15th Annual
Washington University, St. Louis
Thursday, March 20, 2014
2012 Life Science R & D Expenditures: 11th Ranked = $625,450,000. [1]
2013 NIH Funding: 14th Ranked = $320,095,672 [2]
The NIH also awarded two five-year grants totaling $26 million to leukemia researchers and physicians at WU School of Medicine’s Siteman Cancer Center. The funding benefits the center’s ongoing research to identify genetic changes underlying the development and progression of acute myeloid leukemia, as well as a program focused on bringing new investigational treatments into clinical trials. [3]
Washington University received $50 million in funding in order to speed up medical research from discovery to actual application. [4]
WU School of Medicine also received a five-year $7.8 million NIH grant to study the effect of red blood cell storage time on organ failure in children who receive RBC transfusions [5]
Washington University received a $20 million gift to establish the Taylor Family Institute for Innovative Psychiatric Research, which will advance the science underlying the diagnosis and treatment of psychiatric illnesses. [6]
In 2013, the National Institutes of Health awarded the Washington University Institute of Clinical and Translational Sciences $7.7 million in research funding. [7]
WUSTL researchers are looking into ways to combat the most deadly strain of malaria by studying the blood of people with immunity to the parasite, with hopes of eventually developing a vaccine. This research has been supported by funding from the National Institute for Allergy and Infectious Diseases, the Edward Mallinckrodt, Jr. Foundation, an American Heart Association post-doctoral fellowship, and an NSF Graduate Research Fellowship. [8]
On October 1, 2013 WU School of Medicine officially launched the Taylor Family Institute for Innovative Psychiatric Research. The institute supports laboratory and clinical research dedicated to advancing the science underlying the diagnosis and treatment of psychiatric illnesses. [9]
The Children’s Discovery Institute plans to award more than $2.4 million to benefit WU School of Medicine research initiatives focused on congenital heart disease and pediatric intestinal health. [10]
A $2 million grant from the Deutsch-Israel Project was given to WUSTL researchers to continue studies of fire salamanders’ transcriptomes. [11]
Washington University received $6.2 million to apply to innovative biotech research in the fields of genetics and neural circuits. [12]
Washington University received $2 million from "Pedal the Cause" towards cancer research. [13]
The University of Washington received $2 million for unique approaches to treating cancer, including new methods of fighting infection and possibly tumors, and for identifying compounds that don’t harm normal tissues but make malignant tumors more vulnerable to radiation and chemotherapy treatments. [14]
The National Institute of Allergy and Infectious Diseases awarded Washington University St. Louis $1.1 million for the study of B-Cell induction in pediatric lung transplants. [15]
Washington University St. Louis researchers were awarded $2.25 million to study the biomechanics of the brain. [16]
The National Institute of Neurological Disorders and Stroke awarded Washington University St. Louis approximately $1.2 million to study the Abeta peptide's role in the onset of Alzheimer's. [17]
References:
[1] From: HERD Rankings, January 2014: http://webcaspar.nsf.gov/profiles/site?method=rankingBySource&ds=herd
[2] From: Blue Ridge Institute for Medical Research, Ranking Table of NIH Funding (by Institution) to US Medical Schools in 2013, http://www.brimr.org/NIH_Awards/2013/NIH_Awards_2013.htm
[3] From the Washington University in St. Louis Newsroom, October 3, 2013: http://news.wustl.edu/news/Pages/25942.aspx
[4] From St. Louis Post Dispatch, November 19, 2012, http://www.stltoday.com/lifestyles/health-med-fit/health/wash-u-gets-million-to-speed-up-research/article_81d70513-9909-5392-a25d-c8b0a9c1e1a2.html
[5] From the Washington University in St. Louis Newsroom, August 20, 2013: http://news.wustl.edu/news/Pages/25657.aspx
[6] From: Washington University St louis, Oct 6, 2012, http://together.wustl.edu/Pages/News/Andy-Taylor.aspx
[7] From: NIH Research Portfolio Online Reporting Tools (RePORT), January 16 2014: http://projectreporter.nih.gov/project_info_description.cfm?aid=8499472&icde=18926569&ddparam=&ddvalue=&ddsub=&cr=13&csb=AA&cs=DESC
[8] From the Washington University in St. Louis Newsroom, March 20, 2013: http://news.wustl.edu/news/Pages/25138.aspx
[9] From the Washington University in St. Louis Newsroom, September 27, 2013: http://news.wustl.edu/news/Pages/25908.aspx
[10] From the Washington University in St. Louis Newsroom, November 12, 2013: http://news.wustl.edu/news/Pages/26136.aspx
[11] From BCI Science Market Update, July 11, 2013: http://info.biotech-calendar.com/bid/98964/St-Louis-Researchers-Earn-Funds-to-Study-Gene-Shifting-Salamanders
[12] From St. Louis Business Journal, October 11, 2012, http://www.bizjournals.com/stlouis/blog/BizNext/2012/10/three-washington-university-scientists.html
[13] From: Washington University St louis, December 4, 2012, http://news.wustl.edu/news/Pages/24622.aspx
[14] From: Washington University, St. Louis, December 12, 2012, http://news.wustl.edu/news/Pages/24682.aspx
[15] NIH 1/25/2013 http://projectreporter.nih.gov/project_info_details.cfm?aid=8466657&icde=15586747
[16] Washington university Saint Louis 2/22/2013 http://news.wustl.edu/news/Pages/25008.aspx
[17] NIH 5/7/2012 http://projectreporter.nih.gov/project_info_details.cfm?aid=8268731&icde=15586747
2013 NIH Funding: 14th Ranked = $320,095,672 [2]
The NIH also awarded two five-year grants totaling $26 million to leukemia researchers and physicians at WU School of Medicine’s Siteman Cancer Center. The funding benefits the center’s ongoing research to identify genetic changes underlying the development and progression of acute myeloid leukemia, as well as a program focused on bringing new investigational treatments into clinical trials. [3]
Washington University received $50 million in funding in order to speed up medical research from discovery to actual application. [4]
WU School of Medicine also received a five-year $7.8 million NIH grant to study the effect of red blood cell storage time on organ failure in children who receive RBC transfusions [5]
Washington University received a $20 million gift to establish the Taylor Family Institute for Innovative Psychiatric Research, which will advance the science underlying the diagnosis and treatment of psychiatric illnesses. [6]
In 2013, the National Institutes of Health awarded the Washington University Institute of Clinical and Translational Sciences $7.7 million in research funding. [7]
WUSTL researchers are looking into ways to combat the most deadly strain of malaria by studying the blood of people with immunity to the parasite, with hopes of eventually developing a vaccine. This research has been supported by funding from the National Institute for Allergy and Infectious Diseases, the Edward Mallinckrodt, Jr. Foundation, an American Heart Association post-doctoral fellowship, and an NSF Graduate Research Fellowship. [8]
On October 1, 2013 WU School of Medicine officially launched the Taylor Family Institute for Innovative Psychiatric Research. The institute supports laboratory and clinical research dedicated to advancing the science underlying the diagnosis and treatment of psychiatric illnesses. [9]
The Children’s Discovery Institute plans to award more than $2.4 million to benefit WU School of Medicine research initiatives focused on congenital heart disease and pediatric intestinal health. [10]
A $2 million grant from the Deutsch-Israel Project was given to WUSTL researchers to continue studies of fire salamanders’ transcriptomes. [11]
Washington University received $6.2 million to apply to innovative biotech research in the fields of genetics and neural circuits. [12]
Washington University received $2 million from "Pedal the Cause" towards cancer research. [13]
The University of Washington received $2 million for unique approaches to treating cancer, including new methods of fighting infection and possibly tumors, and for identifying compounds that don’t harm normal tissues but make malignant tumors more vulnerable to radiation and chemotherapy treatments. [14]
The National Institute of Allergy and Infectious Diseases awarded Washington University St. Louis $1.1 million for the study of B-Cell induction in pediatric lung transplants. [15]
Washington University St. Louis researchers were awarded $2.25 million to study the biomechanics of the brain. [16]
The National Institute of Neurological Disorders and Stroke awarded Washington University St. Louis approximately $1.2 million to study the Abeta peptide's role in the onset of Alzheimer's. [17]
References:
[1] From: HERD Rankings, January 2014: http://webcaspar.nsf.gov/profiles/site?method=rankingBySource&ds=herd
[2] From: Blue Ridge Institute for Medical Research, Ranking Table of NIH Funding (by Institution) to US Medical Schools in 2013, http://www.brimr.org/NIH_Awards/2013/NIH_Awards_2013.htm
[3] From the Washington University in St. Louis Newsroom, October 3, 2013: http://news.wustl.edu/news/Pages/25942.aspx
[4] From St. Louis Post Dispatch, November 19, 2012, http://www.stltoday.com/lifestyles/health-med-fit/health/wash-u-gets-million-to-speed-up-research/article_81d70513-9909-5392-a25d-c8b0a9c1e1a2.html
[5] From the Washington University in St. Louis Newsroom, August 20, 2013: http://news.wustl.edu/news/Pages/25657.aspx
[6] From: Washington University St louis, Oct 6, 2012, http://together.wustl.edu/Pages/News/Andy-Taylor.aspx
[7] From: NIH Research Portfolio Online Reporting Tools (RePORT), January 16 2014: http://projectreporter.nih.gov/project_info_description.cfm?aid=8499472&icde=18926569&ddparam=&ddvalue=&ddsub=&cr=13&csb=AA&cs=DESC
[8] From the Washington University in St. Louis Newsroom, March 20, 2013: http://news.wustl.edu/news/Pages/25138.aspx
[9] From the Washington University in St. Louis Newsroom, September 27, 2013: http://news.wustl.edu/news/Pages/25908.aspx
[10] From the Washington University in St. Louis Newsroom, November 12, 2013: http://news.wustl.edu/news/Pages/26136.aspx
[11] From BCI Science Market Update, July 11, 2013: http://info.biotech-calendar.com/bid/98964/St-Louis-Researchers-Earn-Funds-to-Study-Gene-Shifting-Salamanders
[12] From St. Louis Business Journal, October 11, 2012, http://www.bizjournals.com/stlouis/blog/BizNext/2012/10/three-washington-university-scientists.html
[13] From: Washington University St louis, December 4, 2012, http://news.wustl.edu/news/Pages/24622.aspx
[14] From: Washington University, St. Louis, December 12, 2012, http://news.wustl.edu/news/Pages/24682.aspx
[15] NIH 1/25/2013 http://projectreporter.nih.gov/project_info_details.cfm?aid=8466657&icde=15586747
[16] Washington university Saint Louis 2/22/2013 http://news.wustl.edu/news/Pages/25008.aspx
[17] NIH 5/7/2012 http://projectreporter.nih.gov/project_info_details.cfm?aid=8268731&icde=15586747
Register by:
12/20/2013 for Early Registration Pricing
Please call 530 272-6675 to sign up for this event.
